Diagnostic Medical Systems has the GF Score of 66, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Diagnostic Medical Systems
might have
Poor future performance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Diagnostic Medical Systems (XPAR:ALDMS) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Diagnostic Medical Systems GF Score Related Terms
XPAR:ALDMS vs ABT, SYK, MDT: GF Score Comparison
For the Medical Devices subindustry, Diagnostic Medical Systems's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostic Medical Systems GF Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's GF Score distribution charts can be found below:
* The bar in red indicates where Diagnostic Medical Systems's GF Score falls into.
Diagnostic Medical Systems (XPAR:ALDMS) has a GF Score of 66 as of Jul. 06, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Diagnostic Medical Systems and its competitors. This is near median its historical median of 62.00. Over the past decade, Diagnostic Medical Systems' GF Score has ranged from 44.00 to 76.00.
Is Diagnostic Medical Systems' GF Score too high?
Diagnostic Medical Systems' current GF Score of 66 is near median its 10-year median of 62.00. Over the past 10 years, this metric has ranged from a low of 44.00 to a high of 76.00. Overall, Diagnostic Medical Systems has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' GF Score compare to ABT and SYK?
Diagnostic Medical Systems' GF Score of 66 can be compared against companies in the Medical Devices & Instruments industry. Historically, Diagnostic Medical Systems' own GF Score has ranged from 44.00 to 76.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Diagnostic Medical Systems and its competitors. Diagnostic Medical Systems's current GF Score is 66, which is near median its own 10-year median of 62.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (XPAR:ALDMS) is currently considered Fairly Valued. The stock's GF Value™ is €1.14, compared to a current price of €1.24 — trading 8.8% above its estimated fair value. The current GF Score is 66, which is near median its 10-year median of 62.00. Diagnostic Medical Systems' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Diagnostic Medical Systems (XPAR:ALDMS), the current GF Score is 66 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnostic Medical Systems (XPAR:ALDMS) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be overvalued.
The current stock price of €1.24 is trading 8.8% above its estimated GF Value™ of €1.14.
GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.
Key valuation signals for XPAR:ALDMS:
GF Score: 66 (near median its 10-year median of 62.00)
GF Value™: €1.14 vs. price of €1.24 (8.8% above fair value)
No single metric tells the full story. See the XPAR:ALDMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
66GF Score
Get the complete analysis for XPAR:ALDMS
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALDMS has been successfully added to your 